Provider review
Ivy Rx review
A microdose specialist that prices the microdose plan dose-flat.
A low starting dose costs the same as a higher one inside the microdose plan, across several formats.
Price as published
Compounded semaglutide microdose $155/mo (4 doses, dose-flat) · standard sema $175/mo · compounded tirzepatide higher
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The verdict
Ivy Rx positions itself specifically around microdosing and prices its microdose plan dose-flat, with injectable, tablet and sublingual formats available — so the format that makes a small dose practical is on the menu rather than an upgrade. Ongoing provider access and delivery are included. Two cautions belong on the same page: non-injectable GLP-1 absorption and efficacy are poorly evidenced and those claims deserve scrutiny rather than trust, and there is no included registered-dietitian support in the base offering. Compounded GLP-1 also sits in a contracting, enforcement-heavy post-shortage legal space.
The trade-off we would want you to read first
Non-injectable (tablet/sublingual) GLP-1 absorption and efficacy are poorly evidenced — scrutinize those claims
Who it suits, and who it does not
A good fit if
- You want a provider whose stated speciality is the low dose itself
- You want a tablet or sublingual format without leaving the programme
- You want ongoing provider access included rather than per-visit
Look elsewhere if
- You want the evidence behind non-injectable absorption to be settled
- You want dietitian support included in the base plan
- You want distance from the current compounded-GLP-1 enforcement picture
How the programme works
Online medical evaluation with ongoing provider access, then compounded semaglutide (microdose and standard) or tirzepatide shipped to you. Ivy Rx positions itself specifically around microdosing and prices the microdose plan dose-flat at $155/mo for four doses, so a low starting dose costs the same as a higher one. Injectable, tablet, and sublingual formats are offered.
At a glance
- Pricing structure
- Flat at every dose
- Consult
- Included in the price
- Compounding
- 503A
- Labs
- Optional
- Dietitian support
- Not included
Strengths
- Explicit microdose program with dose-flat $155/mo pricing — a low dose costs the same as a higher one
- Ongoing provider access and delivery included; multiple formats to start low
The other trade-offs
- Compounded GLP-1s sit in a contracting, enforcement-heavy post-shortage legal space
- No included registered-dietitian support in the base offering
Before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomised trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
Where this sits on the board
Ivy Rx is one of 24 low-dose GLP-1 providers we track. The board lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Funding & disclosures
- A number of links are affiliate or referral links.
- Begin treatment through one and we may earn a commission via the Katalys network — at no added cost to you.
- What we write about a provider is the same either way — unflattering findings about one that pays us stay in.
- Full detail: disclosure page.